Scientists probe how eczema drugs alter skin microbes
NCT ID NCT01631617
First seen Jun 26, 2026 · Last updated Aug 07, 2026 · Updated 14 times
Summary
This study examines how common eczema treatments, including antibiotics and bleach baths, change the types and amounts of bacteria on the skin. Researchers will compare people with eczema to healthy volunteers. The goal is to understand the skin microbiome better, not to test a new treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- antibiotics (trimethoprim/sulfamethoxazole, cephalexin, doxycycline) and dilute bleach
- What this could lead to
- If successful, this could help doctors understand how eczema treatments change skin bacteria, potentially leading to better treatment strategies.
- What could go wrong
- This is an early-phase study focused on measuring bacteria, not on curing or treating eczema. The results may not directly lead to new treatments.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DERMATITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Institutes of Health Clinical Center
RECRUITINGBethesda, Maryland, 20892, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could your daily commute be drying out your skin?
- Real-World dupixent: does it live up to the hype for eczema?
- Can a meditation app soothe teen eczema?
- Can a CBD cream soothe Eczema's relentless itch?
- Can a new drug safely control eczema over the long haul?
- Gene therapy gel targets rare blistering skin disease